These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 17163421)
1. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Chmelar R; Buchanan G; Need EF; Tilley W; Greenberg NM Int J Cancer; 2007 Feb; 120(4):719-33. PubMed ID: 17163421 [TBL] [Abstract][Full Text] [Related]
2. Expression of androgen receptor coregulators in prostate cancer. Linja MJ; Porkka KP; Kang Z; Savinainen KJ; Jänne OA; Tammela TL; Vessella RL; Palvimo JJ; Visakorpi T Clin Cancer Res; 2004 Feb; 10(3):1032-40. PubMed ID: 14871982 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells. Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969 [TBL] [Abstract][Full Text] [Related]
5. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
6. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648 [TBL] [Abstract][Full Text] [Related]
8. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer. Mori R; Wang Q; Quek ML; Tarabolous C; Cheung E; Ye W; Groshen S; Hawes D; Togo S; Shimada H; Danenberg KD; Danenberg PV; Pinski JK Anticancer Res; 2008; 28(1B):425-30. PubMed ID: 18383880 [TBL] [Abstract][Full Text] [Related]
10. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968 [TBL] [Abstract][Full Text] [Related]
11. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Hodgson MC; Astapova I; Hollenberg AN; Balk SP Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755 [TBL] [Abstract][Full Text] [Related]
12. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha. Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943 [TBL] [Abstract][Full Text] [Related]
13. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
14. Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function. Li W; Cavasotto CN; Cardozo T; Ha S; Dang T; Taneja SS; Logan SK; Garabedian MJ Mol Endocrinol; 2005 Sep; 19(9):2273-82. PubMed ID: 15919721 [TBL] [Abstract][Full Text] [Related]
16. [The mechanisms of prostate cancer progression through androgen receptor]. Goto Y; Sakamoto S; Ichikawa T Nihon Rinsho; 2016 Jan; 74(1):55-9. PubMed ID: 26793880 [TBL] [Abstract][Full Text] [Related]
17. Hormonal control of androgen receptor function through SIRT1. Fu M; Liu M; Sauve AA; Jiao X; Zhang X; Wu X; Powell MJ; Yang T; Gu W; Avantaggiati ML; Pattabiraman N; Pestell TG; Wang F; Quong AA; Wang C; Pestell RG Mol Cell Biol; 2006 Nov; 26(21):8122-35. PubMed ID: 16923962 [TBL] [Abstract][Full Text] [Related]
18. Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer. Jaiswal B; Agarwal A; Gupta A Front Endocrinol (Lausanne); 2022; 13():886594. PubMed ID: 36060957 [TBL] [Abstract][Full Text] [Related]
19. A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1). Nazareth LV; Stenoien DL; Bingman WE; James AJ; Wu C; Zhang Y; Edwards DP; Mancini M; Marcelli M; Lamb DJ; Weigel NL Mol Endocrinol; 1999 Dec; 13(12):2065-75. PubMed ID: 10598582 [TBL] [Abstract][Full Text] [Related]
20. The role of the androgen receptor in the development and progression of prostate cancer. Jenster G Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]